PTRCR19 – REGN-COV2 for the treatment of COVID-19 Rapid Collaborative Review- Final Rapid Collaborative Review now available.
This is the third pharmaceutical Rapid Collaborative Review (PTRCR19) published by EUnetHTA. This report describes REGN-COV2 for the treatment of COVID-19 patients. In March 2021,
OTCA27 – Comparative effectiveness of surgical techniques and devices for the treatment of benign prostatic hyperplasia (BPH)- final report now available
The final report is now available for the Relative Effectiveness Assessment OTCA27 “Comparative effectiveness of surgical techniques and devices for the treatment of benign prostatic
EMA-EUnetHTA Bilateral Meeting held today.
The concluding EMA-EUnetHTA Bilateral Meeting under Joint Action 3 was held online today, marking a fitting conclusion to another stage of regular ongoing collaboration that
EUnetHTA-EFPIA Meeting Summary Now Available
We are pleased to publish the summary from the EUnetHTA-EFPIA Technical Meeting, held online on 1st December, 2020. Please follow the link to download. EUnetHTA-EFPIA
EMA-EUnetHTA Bilateral – December 2020 minutes now available
We are please to publish the minutes from the EMA-EUnetHTA Bilateral meeting, held 16 December 2020 online. Thanks to all attendees, and the continuing joint
2021 EUnetHTA Forum Welcome Guide
The 2021 EUnetHTA Forum Welcome Guide is now available. The guide forms a comprehensive overview of EUnetHTA activities as we near completion of Joint Action
2021 EUnetHTA Forum – Agenda
The 2021 EUnetHTA Forum takes place online on 15th April. In advance of this, please follow the link to access the agenda for the day’s
Patient group input requested for new Rapid Reviews on medicinal products for COVID-19.
EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have unique knowledge
EUnetHTA Magazine – Winter 2021 – now available
We are please to finally publish another issue of the EUnetHTA Magazine, a collection of articles submitted by members and stakeholders that deal with HTA
EUnetHTA – Open Letter of Comment
This is an open letter, written by the Chair of the EUnetHTA Executive Board, Niklas Hedberg. It expresses commentary on the role of EUnetHTA within